4-[2-(cyclobutylamino)-8-(2,6-dichloro-4-fluoroanilino)purin-9-yl]-1-methylcyclohexane-1-carboxamide
C23H26Cl2FN7O — CID 121254570
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-(cyclobutylamino)-8-(2,6-dichloro-4-fluoroanilino)purin-9-yl]-1-methylcyclohexane-1-carboxamide
4-[2-(cyclobutylamino)-8-(2,6-dichloro-4-fluoroanilino)purin-9-yl]-1-methylcyclohexane-1-carboxamide (PubChem CID 121254570) has the molecular formula C23H26Cl2FN7O and a molecular weight of 506.41 g/mol. Its IUPAC name is 4-[2-(cyclobutylamino)-8-(2,6-dichloro-4-fluoroanilino)purin-9-yl]-1-methylcyclohexane-1-carboxamide.
Molecular Properties
| Compound Name | 4-[2-(cyclobutylamino)-8-(2,6-dichloro-4-fluoroanilino)purin-9-yl]-1-methylcyclohexane-1-carboxamide |
|---|---|
| PubChem CID | 121254570 |
| Molecular Formula | C23H26Cl2FN7O |
| Molecular Weight | 506.41 g/mol |
| Exact Mass | 505.16 |
| IUPAC Name | 4-[2-(cyclobutylamino)-8-(2,6-dichloro-4-fluoroanilino)purin-9-yl]-1-methylcyclohexane-1-carboxamide |
| SMILES | CC1(C(N)=O)CCC(n2c(Nc3c(Cl)cc(F)cc3Cl)nc3cnc(NC4CCC4)nc32)CC1 |
| InChI | InChI=1S/C23H26Cl2FN7O/c1-23(20(27)34)7-5-14(6-8-23)33-19-17(11-28-21(32-19)29-13-3-2-4-13)30-22(33)31-18-15(24)9-12(26)10-16(18)25/h9-11,13-14H,2-8H2,1H3,(H2,27,34)(H,30,31)(H,28,29,32) |
| InChIKey | VHWPRWIONSKIKG-UHFFFAOYSA-N |
| XLogP | 5.59 |
| TPSA | 110.75 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 506.41 |
| LogP ≤ 5 | 5.59 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121254570 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.